Ashcroft FM,Rorsman P . .Diabetes mellitus and the β cell: the last ten years. Cell. 2012 Mar, 16(6) : 1160-71.
Sharp SA,Weedon MN,Hagopian WA,Oram RA. . .Clinical and research uses of genetic risk scores in type 1 diabetes. Current opinion in genetics & development. 2018 Jun, 1 : 96-102.
Nyaga DM,Vickers MH,Jefferies C,Perry JK,O'Sullivan JM. . .The genetic architecture of type 1 diabetes mellitus. 2018 Dec, 5 : 70-80.
McLaughlin KA,Richardson CC,Ravishankar A,Brigatti C,Liberati D,Lampasona V,Piemonti L,Morgan D,Feltbower RG,Christie MR . .Identification of tetraspanin-7 as a target of autoantibodies in type 1 diabetes. Diabetes. 2016 Jun, 1(6) : 1690-8.
Walther D,Eugster A,Jergens S,Gavrisan A,Weinzierl C,Telieps T,Winkler C,Ziegler AG,Bonifacio E. . .Tetraspanin 7 autoantibodies in type 1 diabetes. Diabetologia. 2016 Sep, 1(9) : 19736.
Steck AK,Vehik K,Bonifacio E,Lernmark A,Ziegler AG,Hagopian WA,She J,Simell O,Akolkar B,Krischer J,Schatz D. . .Predictors of progression from the appearance of islet autoantibodies to early childhood diabetes: The Environmental Determinants of Diabetes in the Young (TEDDY). Diabetes care. 2015 May, 1(5) : 808-13.
Lehuen A,Diana J,Zaccone P,Cooke A .2010 .Im mune cell crosstalk in type 1 diabetes. Nature Reviews Immunology, 10(7) : 501-13.
Willcox A,Richardson SJ,Bone AJ,Foulis AK,Morgan NG .2009 .Analysis of islet inflammation in human type 1 diabetes. Clinical & Experimental Immunology, 155(2) : 73-81.
Walker LS,von Herrath M. CD4 .2016 .T cell differentiation in type 1 diabetes. Clinical & Experimental Immunology, 183(1) : 16-29.
Atkinson MA,Eisenbarth GS,Michels AW . .Type 1 diabetes. The Lancet. 2014 Jan, 4(9911) : 698-2.
Katsarou A,Gudbjörnsdottir S,Rawshani A,Dabelea D,Bonifacio E,Anderson BJ,Jacobsen LM,Schatz DA,A. DA .2017 .Type 1 diabetes mellitus. Nat Rev Dis, Primers3 : 17016.
Imagawa A,Hanafusa T,Miyagawa JI,Matsuzawa Y. . .A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. 2000 Feb, 3(5) : 301-7.
Regnell SE,Lernmark Å . .Early prediction of autoimmune (type 1) diabetes. Diabetologia. 2017 Aug, 1(8) : 1370-81.
D'Addio F,Valderrama Vasquez A,Ben Nasr M .2014 .Autologous nonmyeloablative hematopoietic stem cell transplantation in new-onset type 1 diabetes: a multicenter analysis. Diabetes, 63(9) : 3041-3046.
Trzonkowski P,Bacchetta R,Battaglia M,Berglund D,Bohnenkamp HR,Ten Brinke A,Bushell A,Cools N,Geissler EK,Gregori S . .Hurdlesin therapy with regulatoryT cells. 2015 Sep, 9(304) : 304ps18.
Thomson AW,Zahorchak AF,Ezzelarab MB,Butterfield LH,Lakkis FG,Metes DM . .Prospective clinical testing of regulatory dendritic cells in organ transplantation. 2016 Jan, 28 : 15.
Broichhausen C,Riquelme P,Geissler EK,Hutchinson JA . .Regulatory macrophages as therapeutic targets and therapeutic agents in solid organ transplantation. 2012 Aug, 1(4) : 332-42.
Stendahl JC,Kaufman DB,Stupp SI . .Extracellular matrix in pancreatic islets: relevance to scaffold design and transplantation. Cell transplantation, 18(1) : 1-2.
Pixley JS . .Mesenchymal stem cells to treat type 1 diabetes. Biochimica et Biophysica Acta (BBA)- Molecular Basis of Disease. 2020 Apr, 1(1866) : 165315.
Murai N,Ohtaki H,Watanabe J,Xu Z,Sasaki S,Yagura K,Shioda S,Nagasaka S,Honda K,Izumizaki M. . .Intrapancreatic injection of human bone marrow-derived mesenchymal stem/stromal cells alleviates hyperglycemia and modulates the macrophage state in streptozotocin- induced type 1 diabetic mice. 2017 Oct, 12(10) : e0186637.
Rekittke NE,Ang M,Rawat D,Khatri R,Linn T. .2016 .Regenerative therapy of type 1 diabetes mellitus: from pancreatic islet transplantation to mesenchymal stem cells. 2016 Mar, 7 : .
English K. . .Mesenchymal stem cells to promote islet transplant survival. 2016 Dec, 1(6) : 568-73.
Vegas AJ,Veiseh O,Gürtler M,Millman JR,Pagliuca FW,Bader AR,Doloff JC,Li J,Chen M,Olejnik K,Tam HH . .Long-term glycemic control using polymer-encapsulated human stem cell-derived beta cells in immune-competent mice. 2016 Mar;22, (3) : 306.
Sneddon JB,Tang Q,Stock P,Bluestone JA,Roy S,Desai T,Hebrok M. . .Stem cell therapies for treating diabetes: progress and remaining challenges. 2018 Jun, 1(6) : 810-23.
Spence A,Tang Q. . .Restoring regulatory T cells in type 1 diabetes. 2016 Nov, 1(11) : 110.
Trivedi HL,Vayikra AV,Thakker U,Firoze A,Dave SD,Patel CN,Patel JV,Bhargava AB,Shankar V .2008 .Human adipose tissue-derived mesenchymal stem cells combined with hematopoietic stem cell transplantation synthesize insulin. Transplant Proc, 40(4) : 1135-9.
Trivedi HL,Thakkar UG,Vanikar AV,Dave SD .2011 .Treatment of polyglandular autoimmune syndrome type 3 using co-transplantation of insulin-secreting mesenchymal stem cells and haematopoietic stem cells. Case Reports. 2011 Sep, 5 : bcr0720114436.
Dave SD,Trivedi HL,Chooramani SG,Chandra T. .2013 .Management of type 1 diabetes mellitus using in vitro autologous adipose tissue trans-differentiated insulin-making cells. Case Reports. 2013 Jul, 26 : bcr2013200226.
Carlsson PO,Schwarcz E,Korsgren O . .Le Bla nc K. Preserved β -cell function in type 1 diabetes by mesenchymal stromal cells. Diabetes. 2015 Feb, 1(2) : 587-92.
Carlsson PO,Schwarcz E,Korsgren O,Le Blanc K. Preserved O . .-cell function in type 1 diabetes by mesenchymal stromal cells. Diabetes. 2015 Feb, 1(2) : 587-92.
Kondo Y,Toyoda T,Inagaki N,Osafune K. . .iPSC technology-based regenerative therapy for diabetes. 2018 Mar;9, (2) : 234-43.
Shahjalal HM,Dayem AA,Lim KM,Jeon TI,Cho SG . .Generation of pancreatic β cellsfor treatment of diabetes: advances and challenges. Stem cell research & therapy. 2018 Dec, 1(1) : 355.
Pagliuca FW,Melton DA . .How to make a functional-βcell. 2013 Jun, 140(12) : 2472-83.
Stabler CL,Li Y,Stewart JM,Keselowsky BG JM . .Engineeri ng immunomodulatory biomaterials for type 1 diabetes. 2019 Jun;4, (6) : 429-50.
Al-Khawaga S,Memon B,Butler AE,Taheri S,Abou-Samra AB,Abdelalim EM .2018 .Pathways governing development of stem cell‐derived pancreatic β cells: lessons from embryogenesis. Biological Reviews, 93(1) : 364-89.
Jennings RE,Berry AA,Kirkwood-Wilson R,Roberts NA,Hearn T,Salisbury RJ,Blaylock J,Hanley KP,Hanley NA . .Development of the human pancreas from foregut to endocrine commitment. Diabetes. 2013 Oct, 1(10) : 3514-22.
Stagner JI,Rilo HL,White KK . .The pancreas as an islet transplantation site. Confirmation in a syngeneic rodent and canine autotransplant model. Jop. 2007 Sep, 7(5) : 628-36.
Canibano-Hernandez A,del Burgo LS,Espona-Noguera A,Ciriza J,Pedraz JL . .Current advanced therapy cell-based medicinal products for type-1-diabetes treatment. 2018 May, 30(1-2) : 107-20.
Opara E.C.,Mirmalek-Sani S.H.,Khanna O.,Moya M.L.,Brey E.M. .2010 .Design of a bioartificial pancreas(+). J. Investig. Med, 58 : 831-837.
Langlois G,Dusseault J,Bilodeau S,Tam SK,Magassouba D,Hallé JP . .Direct effect of alginate purification on the survival of islets immobilized in alginate-based microcapsules. 2009 Nov, 1(9) : 3433-40.
Stabler C,Wilks K,Sambanis A,Constantinidis I. . .The effects of alginate composition on encapsulated βTC3 cells. Biomaterials. 2001 Jun, 1(11) : 1301-10.
Omer A,Duvivier-Kali V,Fernandes J,Tchipashvili V,Colton CK,Weir GC . .Lon-tgerm normoglycemia in rats receiving transplants with encapsulated islets. Transplantation. 2005 Jan, 15(1) : 52-8.
Hering BJ,Clarke WR,Bridges ND .2016 .Phase 3 trial of transplantation of human islets in type 1 diabetes complicated bysevere hypoglycemia. Diabetes Care, 39 : 1230-40.
Kasputis T,Clough D,Noto F,Rychel K,Dye B,Shea LD . .Microporous polymer scaffolds for the transplantation of embryonic stem cell derived pancreatic progenitors to a clinically translatable site for the treatment of type I diabetes. ACS biomaterials science & engineering. 2018 Apr, 17(5) : 17708.
Shapiro AM,Lakey JR,Ryan EA .2000 .Islet transplantation in seven patients with type 1diabetes mellitus usingaglucocorticoid-free immunosuppressive regimen. N Engl J Med, 343 : 230-38.
Rickels MR,Liu C,Shlansky-Goldberg RD,Soleimanpour SA,Vivek K,Kamoun M,Min Z,Markmann E,Palangian M,Dalton-Bakes C . .Improvement in β-cell secretory capacity after human islet transplantation according to the CIT07 protocol. Diabetes. 2013 Aug, 1(8) : 2890-7.
Gerber PA,Locher R,Zuellig RA,Tschopp O,Ajdler-Schaeffler E,Kron P,Oberkofler C,Brändle M,Spinas GA,Lehmann R.,Glycemia R. . .costs of simultaneous islet-kidney or islet after kidney transplantation versus intensive insulin therapy and waiting list for islet transplantation. Transplantation. 2015 Oct, 1(10) : 2174-80.
Vantyghem MC,Kerr-Conte J,Arnalsteen L,Sergent G,Defrance F,Gmyr V,Declerck N,Raverdy V,Vandewalle B,Pigny P,Noel C . .Primary graft function, metabolic control, and graft survival after islet transplantation. Diabetes care. 2009 Aug, 1(8) : 1473-8.
Thompson DM,Meloche M,Ao Z,Paty B,Keown P,Shapiro RJ,Ho S,Worsley D,Fung M,Meneilly G,Begg I. . .Reduced progression of diabetic microvascular complications with islet cell transplantation compared with intensive medical therapy. Transplantation. 2011 Feb, 15(3) : 373-8.
Lablanche S,Vantyghem MC,Kessler L,Wojtusciszyn A,Borot S,Thivolet C,Girerd S,Bosco D,Bosson JL,Colin C,Tetaz R . .Islet transplantation versus insulin therapy in patients with type 1 diabetes with severe hypoglycaemia or poorly controlled glycaemia after kidney transplantation (TRIMECO): a multicentre, randomised controlled trial. The Lancet Diabetes & Endocrinology. 2018 Jul, 1(7) : 527-37.
Speight J,Reaney MD,Woodcock AJ,Smith RM,Shaw JA .2010 .Patient-reported outcomes following islet cell or pancreas transplantation (alone or after kidney) in Type 1 diabetes: a systematic review. Diabetic Medicine, 27(7) : 812-22.
Ferraro A,Socci C,Stabilini A,Valle A,Monti P,Piemonti L,Nano R,Olek S,Maffi P,Scavini M,Secchi A . .Expansion of Th17 cells and functional defects in T regulatory cells are key features of the pancreatic lymph nodes in patients with type 1 diabetes. Diabetes. 2011 Nov, 1(11) : 2903-13.
Vantyghem MC,de Koning EJ,Pattou F,Rickels MR . .Advances in β-cell replacement therapy for the treatment of type 1 diabetes. The Lancet. 2019 Oct, 5(10205) : 12748-5.
Sordi V,Pellegrini S,Krampera M,Marchetti P,Pessina A,Ciardelli G,Fadini G,Pintus C,Pantè G,Piemonti L . .Stem cells to restore insulin production and cure diabetes. 2017 Jul, 1(7) : 583-600.
Klinker MW,Wei CH . .Mesenchymal stem cells in the treatment of inflammatory and autoimmune diseases in experimental animal models. 2015 Apr, 26(3) : 556.
Sohni A,Verfaillie CM .2013 .Mesenchymal stem cells migration homing and tracking. , : .
Zhao Y,Mazzone T . .Human cord blood stem cells and the journey to a cure for type 1 diabetes. 2010 Dec, 1(2) : 103-7.
Mesples A,Zhang Y,Hu X .2013 .Early immunotherapy using autologous adult stem cells reversed the effect of anti-pancreatic islets in recently diagnosed type 1 diabetes mellitus: preliminary results. Medical science monitor: international medical journal of experimental and clinical research, 19 : 852.
Wu H,Wen D,Mahato RI . .Third-party mesenchymal stem cells improved human islet transplantation in a humanized diabetic mouse model. 2013 Sep, 1(9) : 1778-86.
Gimble JM,Katz AJ,Bunnell BA . .Adipose-derived stem cells for regenerative medicine. 2007 May, 11(9) : 1249-60.
Gerace D,Martiniello-Wilks R,Nassif NT,Lal S,Steptoe R,Simpson AM . .CRISP-tRargeted genome editing of mesenchymal stem cell-derived therapies for type 1 diabetes: a path to clinical success?. Stem cell research & therapy. 2017 Dec, 1(1) : 62.
Villani V,Milanesi A,Sedrakyan S,Da Sacco S,Angelow S,Conconi MT,Di Liddo R,De Filippo R . .Amniotic fluid stem cells prevent β-cell injury. Cytotherapy. 2014 Jan, 1(1) : 41-55.
D'Amour KA,Agulnick AD,Eliazer S .2005 .Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat Biotechnol, 23(12) : 1534-1541.
D'Amour KA,Bang AG,Eliazer S,Kelly OG,Agulnick AD,Smart NG,Moorman MA,Kroon E,Carpenter MK,Baetge EE . .Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nature biotechnology, 24(11) : 1392-401.
Pagliuca FW,Millman JR,Gurtler M . .Generation of functional human pancreatic beta cells in vitro. Cell. 2014 Oct, 9 : 159.
Rezania A,Bruin JE,Arora P,Rubin A,Batushansky I,Asadi A,O'dwyer S,Quiskamp N,Mojibian M,Albrecht T,Yang YH . .Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells. Nature biotechnology, 32(11) : 1121.
lanus A,Holz GG,Theise ND,Hussain MA .2003 .In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J Clin Invest, 111(6) : 843-50.
Ersek A,Pixley JS,Goodrich AD,Porada CD,Almeida-Porada G,Thain DS . .Persistent circulating human insulin in sheep transplanted in utero with human mesenchymal stem cells. 2010 Apr, 1(4) : 311-20.
Bonini C,Bondanza A,Perna SK,Kaneko S,Traversari C,Ciceri F,Bordignon C. . .The suicide gene therapy challenge: how to improve a successful gene therapy approach. 2007 Jul, 1(7) : 1248-52.
Yagyu S,Hoyos V,Del Bufalo F,Brenner MK . .An inducible caspase-9 suicide gene to improve the safety of therapy using human induced pluripotent stem cells. 2015 Sep, 1(9) : 1475-85.
Guo S,Dai C,Guo M,Taylor B,Harmon JS,Sander M,Robertson RP,Powers AC,Stein R . .Inactivation of specific β cell transcription factors in type 2 diabetes. 2013 Aug, 1(8) : 3305-16.